AR Training Versus Patching in Unilateral Amblyopia
Condition(s) studied
Investigational drug(s) / intervention(s)
AR training: Dichoptic augmented reality training with dual-pathway (parvocellular pathway and magnocellular pathway) and interocular push-pull paradigms developed based on neural deficits in unilateral amblyopia.
Patching: Conventional patching therapy.
Study summary
This is a multi-center, randomized controlled trial to compare the effectiveness of AR training with patching for the treatment of unilateral amblyopia.
Specific Aim 1 (Primary): To compare the improvement of visual acuity in the amblyopic eye between AR training and patching for the treatment of unilateral amblyopia.
Specific Aim 2 (Secondary): To compare the improvement of visual functions between AR training and patching for the treatment of unilateral amblyopia.
Eligibility
Primary outcome measure(s)
- Total effective rate — 13 weeks
The effective rate is defined as the proportion of patients whose best-corrected visual acuity (BCVA) at distance improved ≥0.2 LogMAR after treatment compared to the baseline. BCVA at distance is measured with ETDRS chart.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Eye & ENT Hospital of Fudan University | Shanghai | China | Recruiting |
More Eye & ENT Hospital of Fudan University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06498206 on ClinicalTrials.gov ↗ ← All trials in China